Microfabrica Partners with US Endoscopy

SANTA CLARA, CA – Microfabrica partners with US Endoscopy to produce the world's first submillimeter biopsy forceps, designed to improve the reliability of tissue biopsy in the GI tract including biopsy of pancreatic cystic lesions. Pancreatic cancer is the fourth leading cause of cancer-related deaths in the US, estimated to surpass breast cancer in 2017.

Like 3D Printing, Microfabrica can produce complex three dimensional structures, with moving parts, in layers, directly from a digital model. Unlike 3D Printing, Microfabrica leverages the semiconductor manufacturing paradigm, enabling them to produce high precision, micro scale metal devices in commercial volumes. These structures require no assembly and the entirety of the mechanism is monolithically fabricated by Microfabrica.

For more information, visit:
http://www.microfabrica.com
http://www.usendoscopy.com

Suggested Articles

The overall data center system matters more than the CPU to CIOs, but investors responded poorly to Intel’s lower data centric chip sales

The world’s largest chipmaker saw a 47% decline in data center sales to enterprise and government, even as it forecast a full year 2020 record of $75B

Working with Jacoti of Belgium, Qualcomm wants to make earbuds recognize the hearing anomalies of users.